Envision is the new in-office standard revolutionising ocular care procedures for the treatment of meibomian gland dysfunction (MGD) and the symptoms of dry eye disease (DED).

Morpheus8 delivers the deepest fractional treatments available, penetrating subdermal tissue up to 8mm (7mm + 1mm thermal profile).

This ground breaking, non-surgical ophthalmic device, deploys multiple programmable modalities which work synergistically to deliver precision ocular treatments.

Four fractional tips with different microneedle configurations for customised treatments (Prime 12 pin, Resurfacing 24 pin, Morpheus8 24 pin, and Body 40 pin) deliver clinically proven RF energy to multiple treatment depths (0.5mm – 7mm).

Envision’s small-size, bipolar radiofrequency (RF) and Intense Pulsed Light (IPL) applicators with precise depth control allowing for highly efficacious procedures in the small, more delicate subdermal layers of the periorbital region.

Equipped with Burst mode RF technology, Morpheus8 Body automatically deploys bipolar RF energy to multi-level treatment depths in a single cycle. The ability to target tissue sequentially at three levels, in millisecond intervals, allows for a significant reduction in treatment times, minimizes skin injury, increases treatment uniformity, and enables customized full body fractional procedures.

The Morpheus8 Prime fractional radio-frequency microneedling technology allows for droopy eyelids to be tightened.

Equipped with Burst mode RF technology, Morpheus8 Body automatically deploys bipolar RF energy to multi-level treatment depths in a single cycle. The ability to target tissue sequentially at three levels, in millisecond intervals, allows for a significant reduction in treatment times, minimizes skin injury, increases treatment uniformity, and enables customized full body fractional procedures.